Guidelines of official societies for diagnosis and therapy of intraoperatively occurring hypocoagulability rely mainly on data of patients receiving whole blood transfusions...
Keywords: Hämostase, Labormethoden, PT, aPTT, Fibrinogen, Blutverlust, Volumentherapie, Thrombelastographie/Thrombelastometrie, TEG, ROTEM
01/2006 | Hämostaseologie, SchattauerAn increased erythrocyte aggregation (EA) is associated with capillary slow flow, tissue hypoxemia and endothelial dysfunction...
Keywords: Erythrocyte aggregation, fibrinogen, gene polymorphism
03/2006 | Thrombosis and Haemostasis, SchattauerQuantification of fibrinopeptides release is widely used to investigate fibrinogen activation, and standard chromatographic or capillary electrophoretic procedures are readily available...
Keywords: blood coagulation, human, fibrinogen, fibrinopeptides, chromatography, Mass spectrometry
09/2006 | Thrombosis and Haemostasis, SchattauerDiabetic subjects have been shown to have altered fibrin network structures. One possible cause may be fibrinogen glycation resulting in altered structure/function properties...
Keywords: diabetes, glycation, fibrinogen, fibrin network structure, glucose control
11/2006 | Thrombosis and Haemostasis, SchattauerFibrin network structure has been correlated with coronary disease. Fibrinogen and (FGG and FGA) gene haplotypes (chromosome 4q28) may be associated with fibrin network structure, and thereby with rigidity of the fibrin clot and sensitivity of the fibrin clot to the fibrinolytic system...
Keywords: Coronary disease, atherosclerosis, epidemiology, genetics, fibrinogen
00/0000 | Thrombosis and Haemostasis, SchattauerCongenital afibrinogenemia (CAF) is a rare coagulation disorder characterized by very low or unmeasurable levels of functional and immunoreactive fibrinogen in plasma, associated with a hemorrhagic phenotype of variable severity...
Keywords: fibrinogen, congenital afibrinogenemia, mutational screening, large deletion, point mutations
04/2007 | Thrombosis and Haemostasis, SchattauerKeywords: fibrinogen, hematocrit, length of sedimentation reaction, TEST 1, Westergren method
04/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: apolipoprotein B, familial hypercholesterolemia, fibrinogen, lipoprotein lipase, paroxonase, polymorphisms
07/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: fibrinogen, length of sedimentation reaction in blood, M-proteins, rheumatological diseases, TEST 1, Westergren method
07/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: apolipoprotein E polymorphism, C-reactive protein, fibrinogen, lipoprotein(a), offspring of survivors of myocardial infarction
11/2008 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: Citrate, C-reactive protein, EDTA, fibrinogen
08/2008 | Clinical Chemical Laboratory Medicine, Walter de GruyterAccumulating evidence suggests that a metabolite of homocysteine (Hcy), the thioester Hcy-thiolactone, plays an important role in atherogenesis and thrombosis...
Keywords: atherosclerosis, autoantibodies, cystathionine ?-synthase (CBS), dietary hyperhomocysteinemia, fibrinogen, genetic hyperhomocysteinemia, homocysteine thiolactone hypothesis, immune activation, methylenetetrahydrofolate reductase (MTHFR), protein N-homocysteinylation, thrombosis
12/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterZusammenfassung Im Gegensatz zu den klassischen Gerinnungsparametern ermöglicht die Thrombelastographie/-metrie auch eine Beurteilung der Gerinnselfestigkeit und -stabilität...
Keywords: Clotfestigkeit, fibrinogen, Hyperfibrinolyse, Rotationsthrombelastometrie, Thrombozyten, clot strength, hyperfibrinolysis, thrombelastography/-metry, thrombocytes
12/2007 | LaboratoriumsMedizin, Walter de Gruyter